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The evaluation by IARC (1992) concluded that ‘There is sufficient
evidence in humans for the carcinogenicity of solar radiation. Solar
radiation causes cutaneous malignant melanoma and non-
melanocytic skin cancer. There is limited evidence in humans for
the carcinogenicity of exposure to ultraviolet (UV) radiation from
sunlamps and sun beds’.
In assessing the quantitative contribution of different exposures
to cancer in the UK, we are not concerned with non-melanoma
skin cancers. This is because there is no agreed method of
enumerating such tumours, which may occur at multiple skin sites
throughout life, and, because of their generally trivial nature, are in
any case under-enumerated in registration systems.
Evaluation of the proportion of total cases of malignant
melanoma that is related to solar (UV) exposure poses many
problems. Clearly, the method of estimation based on prevalence
of exposure and relative risk is inappropriate, given that there is no
‘unexposed’ population, and the distribution of relevant types of
exposure is unknown.
We have therefore estimated the UV-attributable cases occur-
ring in 2010 as the difference between the number observed and
those that would have been expected with a theoretical-minimum-
risk exposure distribution, based on historical data from UK.
These historical data are the estimated incidence rates for the
generation of individuals born in 1903, resident in the South
Thames region of England.
METHODS
Over the last 30 years, the incidence of malignant melanoma has
increased more than for any other common cancer in the UK; in
males the age-standardised (European standard) rate rose from 2.5
in 1975 to 14.6 in 2007, and it is projected to be 17.0 in 2010; the
female age-standardised rate has increased fourfold – from 3.9 to
15.4 – over the same period, with a projected value of 18.0 in 2010.
The longest series of high-quality incidence data in the UK, with
incidence rates from 1960 onwards, is from the South Thames
region (Parkin et al, 2005). Figures 1 and 2 show the trends in
incidence between 1960 and 1997 in males and females,
respectively.
We fitted an age-cohort model to the South Thames data to
reconstruct age-specific incidence rates for age groups without
actual observations, and selected the estimated incidence rates in
the cohort born in 1903 as our ‘reference’, with which to calculate
expected numbers of cases in 2010, if solar exposure had been as
modest as in the 1903 cohort. Age-standardised incidence rates in
this generation are some 10-fold lower in males and 6-fold lower
in females than those estimated for 2010, but the disparity
is considerably greater in the young than in the elderly (Figure 3).
RESULTS
Table 1 shows the projected numberso fc a s e so fm e l a n o m ai nt h eU K
in 2010 (6096 in men and 6822 in women), and the number expected
in the same year if the rates in the 1903 South Thames cohort had
been applied. Overall, some 90% of melanoma cases in men and 82%
in women are estimated to be attributed to ‘excess’ solar irradiation,
although the attributable fractions are very much greater at younger
ages. The overall attributable fraction (85.9% of melanoma) is
equivalent to 3.5% of all new cancer cases in the UK in 2010.
DISCUSSION
With respect to malignant melanoma the evidence for carcino-
genicity of solar radiation is derived from various sources.
Descriptive studies (in white populations) show a positive
association between incidence of and mortality from melanoma
and residence at lower latitudes. Studies of migrants suggest that
the risk of melanoma is related to solar radiant exposure at the
place of residence in early life. The body-site distribution of
melanoma favours sites usually exposed to the sun. Evidence from
a large number of case–control studies is generally consistent with
positive associations with residence in sunny environments
throughout life, in early life and even for short periods in early
adult life. Positive associations are generally seen between
measurements of cumulative sun damage, expressed biologically
as microtopographical changes or history of keratoses or non-
melanocytic skin cancer, and measures of intermittent exposure to *Correspondence: Professor DM Parkin; E-mail: d.m.parkin@qmul.ac.uk
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www.bjcancer.comthe sun (such as particular sun-intensive activities, outdoor
recreation or vacations) and with a history of sunburn. In contrast,
chronic exposure, as assessed through occupational exposure,
appears to reduce the melanoma risk, an observation consistent
with the descriptive epidemiology of the condition, which shows
lower risks in groups that work outdoors.
Previous evaluations of the propor t i o no ft o t a lc a s e so fm a l i g n a n t
melanoma that is related to solar (UV) exposure have also relied on the
direct method of estimating attributable risk: the difference between
observed incidence in the population and incidence in an ‘unexposed’
reference group. In a widely quoted study, Armstrong and Kricker
(1993) used three different estimates of incidence in ‘unexposed’
populations to compare with the observed rates in Australia:
 The incidence of melanoma at body sites unexposed to the sun
(buttocks and (in women) the scalp, from the Queensland
Cancer Registry in 1987; Green et al, 1993).
 The incidence from areas of lower sun exposure in migrants to
Australia.
 Ac o m p a r i s o no fU SW h i t e sa n dU SBlacks, in which the incidence
in Blacks was taken as the incidence in unexposed Whites.
In the evaluation of avoidable cancers in the Nordic countries,
Winther et al (1997) used the crude incidence rates of melanoma at
unexposed sites from the above study as the baseline ‘unexposed’
and estimated attributable fraction in Nordic countries from this
study. The IARC’s assessment of causes of cancer in France
(IARC, 2007) simply took the attributable fraction calculated by
Armstrong and Kricker (1993) for Australia as relevant to France
in the year 2000. In the evaluation in this section, we chose to use
rates from an ‘unexposed’ reference population that is relevant to
UK – the generation born in 1903 in the South Thames region of
England.
The pattern of increasing incidence of malignant melanoma in
this population over time is a feature of many fair-skinned
populations (Lens and Dawes, 2004). In Europe, the increases
began first with Scandinavia and the UK and then spread to
western, southern and eastern Europe (de Vries et al, 2003). The
increase has been mainly for thin melanomas (Lipsker et al, 1999;
Mackie et al, 2002). Some of the increase may be due to increased
surveillance and early detection, as well as changes in diag-
nostic criteria, but much of the increase is considered to be real
(van der Esch et al, 1991) and linked to changes in sun behaviour
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Figure 1 Trends in incidence of malignant melanoma in the South Thames region, 1960–1997, males.
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Figure 2 Trends in incidence of malignant melanoma in South Thames region, 1960–1997, females.
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Coebergh, 2005). Although the trends observed in South Thames
could equally well be related to an increase in risk by period of
diagnosis, or by birth cohort, we assume that they are in fact due
to changes in exposure to solar UV exposure because of altered
patterns of behaviour (in choice of clothing and recreational
sunshine), producing an increase in incidence that is cohort-
specific. This Edwardian generation almost certainly had little
bodily exposure to sunlight in their childhood, and even as young
adults opportunities for vacations in sunny climates would have
been very limited (Figure 4). Nevertheless, exposure was not zero,
so that, even at almost 86%, an estimate of PAF will be something
of an underestimate.
In a recent update to its evaluation of the carcinogenicity of UV
irradiation, IARC reaffirmed the carcinogenicity of solar radiation,
but the classification of the use of UV-emitting tanning devices was
raised to Group 1, ‘carcinogenic to humans’ (El Ghissassi et al,
2009). A part of the increase in incidence rates in contemporary
UK may well be due to use of sunlamps, but since these devices will
almost certainly not have been used by any of the 1903-born
Table 1 Malignant melanoma cases diagnosed in 2010, estimated to be
due to exposure to solar (ultraviolet) radiation
Malignant melanoma All cancer
a
Age
(years)
Relative
risk
Observed
cases
Excess
attributable
cases (PAF)
Observed
cases
Excess
attributable
cases (PAF)
Males
o25 33.50 78 75.7 (97.0) 1853 75.7 (4.1)
25–34 32.37 284 275.2 (96.9) 2109 275.2 (13.0)
35–49 21.98 1042 994.6 (95.4) 8359 994.6 (11.9)
50–64 13.88 1717 1593.3 (92.8) 37617 1593.3 (4.2)
X65 6.81 2975 2538.4 (85.3) 108729 2538.4 (2.3)
Total 6096 5477 (89.8) 158667 5477.2 (3.5)
Females
o25 19.31 199 188.7 (94.8) 1646 188.7 (11.5)
25–34 14.18 561 521.4 (92.9) 3284 521.4 (15.9)
35–49 9.72 1551 1391.4 (89.7) 16877 1391.4 (8.2)
50–64 6.89 1816 1552.4 (85.5) 41338 1552.4 (3.8)
X65 3.69 2695 1965.6 (72.9) 92439 1965.6 (2.1)
Total 6822 5620 (82.4) 155584 5619.6 (3.6)
Persons
o25 277 264 (95.4) 3500 264 (7.6)
25–34 845 797 (94.3) 5393 797 (14.8)
35–49 2593 2386 (92.0) 25236 2386 (9.5)
50–64 3533 3146 (89.0) 78955 3146 (4.0)
X65 5670 4504 (79.4) 201167 4504 (2.2)
Total 12918 11097 (85.9) 314251 11097 (3.5)
Abbreviations: PAF, population-attributable fraction (%).
aExcluding non-melanoma
skin cancer.
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Figure 3 Malignant melanoma: incidence in UK 2010 and South Thames
1903 birth cohort.
Figure 4 Holiday makers on the beach around 1919–1921.
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the differences in incidence rates remains a valid approach.
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